<- Go Home

Miromatrix Medical Inc.

As of December 13, 2023, Miromatrix Medical Inc. was acquired by United Therapeutics Corporation. Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company’s proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Market Cap

$93.0M

Volume

39.9K

Cash and Equivalents

$6.1M

EBITDA

-$27.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$458.0K

Profit Margin

47.81%

52 Week High

$4.35

52 Week Low

$0.91

Dividend

N/A

Price / Book Value

5.98

Price / Earnings

-3.03

Price / Tangible Book Value

5.98

Enterprise Value

$80.1M

Enterprise Value / EBITDA

-2.98

Operating Income

-$28.6M

Return on Equity

113.53%

Return on Assets

-55.84

Cash and Short Term Investments

$16.1M

Debt

$3.2M

Equity

$15.5M

Revenue

$958.0K

Unlevered FCF

-$14.4M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches